Preclinical data showed that GSK2256098 treatment reduces microvessel density and cellular proliferation and induces apoptosis more efficiently in PTEN-mutated than in PTEN wt uterine cancer cells [63]. The gene discussed is PTEN; the disease is uterine cancer.